A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study

Yung-Jue Bang; E. Van Cutsem; W Mansoor; Russell Petty; Y. Chao; David Cunningham; David Ferry; Donal Landers; Paul K. Stockman; N Smith; C Geh; Elaine Kilgour

A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study

Yung-Jue Bang, E. Van Cutsem, W Mansoor, Russell Petty, Y. Chao, David Cunningham, David Ferry, Donal Landers, Paul K. Stockman, N Smith, C Geh, Elaine Kilgour

Cancer Research UK Manchester Institute

Research output: Contribution to journal › Article

Original language	English
Journal	Journal of Clinical Oncology
Volume	33
Issue number	15
Publication status	Published - 31 Jan 2017

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Bang, Y.-J., Van Cutsem, E., Mansoor, W., Petty, R., Chao, Y., Cunningham, D., Ferry, D., Landers, D., Stockman, P. K., Smith, N., Geh, C., & Kilgour, E. (2017). A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study. Journal of Clinical Oncology, 33(15).

@article{4b849eecb75243069c6e518f65ee91a0,

title = "A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study",

author = "Yung-Jue Bang and \{Van Cutsem\}, E. and W Mansoor and Russell Petty and Y. Chao and David Cunningham and David Ferry and Donal Landers and Stockman, \{Paul K.\} and N Smith and C Geh and Elaine Kilgour",

year = "2017",

month = jan,

day = "31",

language = "English",

volume = "33",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "15",

}

Bang, Y-J, Van Cutsem, E, Mansoor, W, Petty, R, Chao, Y, Cunningham, D, Ferry, D, Landers, D, Stockman, PK, Smith, N, Geh, C & Kilgour, E 2017, 'A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study', Journal of Clinical Oncology, vol. 33, no. 15.

A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study. / Bang, Yung-Jue; Van Cutsem, E.; Mansoor, W et al.
In: Journal of Clinical Oncology, Vol. 33, No. 15, 31.01.2017.

Research output: Contribution to journal › Article

TY - JOUR

T1 - A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study

AU - Bang, Yung-Jue

AU - Van Cutsem, E.

AU - Mansoor, W

AU - Petty, Russell

AU - Chao, Y.

AU - Cunningham, David

AU - Ferry, David

AU - Landers, Donal

AU - Stockman, Paul K.

AU - Smith, N

AU - Geh, C

AU - Kilgour, Elaine

PY - 2017/1/31

Y1 - 2017/1/31

M3 - Article

SN - 0732-183X

VL - 33

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -